1,020 filings
Page 10 of 51
8-K
z37xjyzgvp0rgpph ic
21 Dec 20
Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board
4:18pm
8-K
30pn0h6q2v3xw0ren
7 Dec 20
Cardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AML
1:22pm
4
7ox2c d22
25 Nov 20
Cardiff Oncology / Vicki Kelemen ownership change
4:02pm
8-K
f6l u3i55ck
23 Nov 20
Cardiff Oncology to Participate in Fireside Chat at the Piper Sandler 32nd Annual Healthcare Conference
11:54am
8-K
jkmwh04elks9pmp8 wc
5 Nov 20
Cardiff Oncology Announces Third Quarter 2020 Results and Highlights
4:09pm
SC 13G
35y iplwe2
4 Nov 20
Cardiff Oncology / Venrock Healthcare Capital Partners III ownership change
4:54pm
8-K
kc61ykt0nbjth3fxt95
20 Oct 20
Cardiff Oncology Presents Positive Efficacy and Biomarker Data from mCRPC Trial Demonstrating Ability of Onvansertib to Overcome Zytiga® Resistance
11:59am
SC 13G
tkcfejvnf v62cd48
9 Oct 20
Cardiff Oncology / RA CAPITAL MANAGEMENT ownership change
4:29pm
3
usu9c2ma 4m00jhg4
2 Oct 20
Cardiff Oncology / Rajeev M. Shah ownership change
4:30pm
8-K
7gh5lm
30 Sep 20
Cardiff Oncology Announces Proposed Public Offering
4:09pm
424B5
anxzyflp9kfg 10
30 Sep 20
Prospectus supplement for primary offering
4:00pm
424B5
75ubopm
29 Sep 20
Prospectus supplement for primary offering
4:00pm
8-K
b5963 fa4rkfgv8
22 Sep 20
Regulation FD Disclosure
12:00am
8-K
3454yy0 4rzfgayifmf
17 Sep 20
Other Events
11:18am
4
yljdex9r
17 Sep 20
Cardiff Oncology / GARY W PACE ownership change
9:42am
8-K
qsyw7jb69p11ah5vf5gs
15 Sep 20
Cardiff Oncology to Host Key Opinion Leader Call Discussing KRAS-Mutated Colorectal Cancer and Highlighting Data from Onvansertib Phase 1b/2 Trial
10:36am
8-K
4y4g59ci0
14 Sep 20
Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer Patients
11:55am
SC 13G
k60qqnp018w8bsal2
28 Aug 20
Cardiff Oncology / Opaleye Management ownership change
5:15pm
8-K
7h0tkzbrx9mu1vv6
11 Aug 20
Cardiff Oncology Announces Second Quarter 2020 Results and Highlights
4:04pm